RecruitingNCT03753412

Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

Prospective Observational Study Regarding the Determinants of Functional Disability and Quality of Life in Patients Recovering From Severe Acute Cardiac or Respiratory Failure Considered for Mechanical Cardiorespiratory Support (CLEVERER)

Sponsor

Barts & The London NHS Trust

Enrollment

100 participants

Start Date

Apr 9, 2019

Study Type

OBSERVATIONAL

Conditions

Respiratory Failure Cardiac Failure Acute Respiratory Distress Syndrome Intensive Care Unit Syndrome Intensive Care Neuropathy Intensive Care (ICU) Myopathy Critical Illness Myopathy

Summary

To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Above the age of 18
Adults with severe cardio-respiratory failure requiring ECMO.
Adults who have had personal and professional consultees agree to enrol them in the trial.

Exclusion Criteria5

Previous Stroke
Neuromuscular disease
Malignancy
Underlying neuromuscular disease
paediatrics

Locations(1)

St Bartholomew's hospital (Barts NHS trust)

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03753412

Related Trials

Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome

NCT074508461 location

Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure

NCT066289732 locations